Head-to-head · Value Score
Vitara RX vs Revive Meds
Two GLP-1 deals, scored on the same six factors. Vitara RX lands a Value Score of 91, Revive Meds a 60. Here's who gives you the honest lower price — and where each one bites back.
Vitara RX
#4 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameRevive Meds
#342 · Grade C · Watch List
Est. first month
From $369/mo (starting dose, compounded)
Save ~73% vs brand-nameThe verdict
Vitara RX takes it on Value Score, 91 to 60 — an est. $99/mo first month, with no teaser step-up baked in. Revive Meds isn't out of it: Shoppers who want pay-per-order compounded GLP-1 (with B12) buyers who prepay multi-month for the lowest per-month cost.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Vitara RX | Revive Meds |
|---|---|---|
| Value Score | 91 (A) | 60 (C) |
| Est. first month | $99/mo | From $369/mo (starting dose, compounded) |
| Save vs brand-name | ~93% | ~73% |
| Semaglutide | $99/mo | From $369/mo (starting dose, compounded) |
| Tirzepatide | $149/mo | From $459/mo (starting dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | 49 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Vitara RX
VitaraRx is a direct-to-consumer telehealth marketplace offering compounded semaglutide and tirzepatide at flat per-drug pricing across all doses — no membership or hidden fees.
Why it's a deal
- Among the lowest flat pricing in the market — $99/mo semaglutide and $149/mo tirzepatide, all doses same price
- Names its 503A pharmacy partner (Manifest Pharmacy, Greer SC) — strong supply-chain transparency
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer
- Covers 49 states with an explicit state list, not vague "most states" language
The fine print
- No corporate legal entity disclosed — only the trade name "VitaraRx"
- No named medical director — all clinical decisions made by independent providers (marketplace model)
- All sales final — no medication returns
- Per-vial mg quantity isn't clearly disclosed, making price comparisons harder
- Doesn't ship to Alaska
Revive Meds
Revive Meds (revive-meds.com, Revive Health Therapy) is a nationwide GLP-1 and longevity telehealth service that sells compounded semaglutide and dual-agonist tirzepatide, each combined with vitamin B12…
Why it's a deal
- Offers both compounded semaglutide and dual-agonist tirzepatide, each combined with vitamin B12 (cyanocobalamin) in a single injection
- Pay-per-order model with no subscription, sign-up fees, or long-term commitment, and free shipping on every order
- Names its six 503A compounding pharmacies and two prescribing physicians, which is unusually transparent on fulfillment
- Available in all 50 states and HSA/FSA eligible through a Medical Necessity Letter
- Prepaying 3 to 12 months cuts the effective cost to as low as $202/mo (semaglutide) or $300/mo (tirzepatide)
The fine print
- Month-to-month pricing is steep: $369/mo semaglutide and $459/mo tirzepatide unless you prepay several months
- No public price list; pricing appears only after you complete a full health intake and create an account
- Not LegitScript-certified (no seal displayed on the site)
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Vitara RX is ranked on the Vitara RX alternatives board, and the same list for the other side is on alternatives to Revive Meds.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.